Dr. Shahrukh Hashmi has been at Mayo Clinic for approximately 10 years. He started Mayo Clinic’s first BMT survivorship program. He has served as PI or Co-PI on many industry-sponsored and NIH sponsored trials. His research interests include premature aging and GVHD. He is also involved in stem cell therapeutics particularly in regenerative hematology. He has authored >200 articles in peer-reviewed journals, including in JAMA, Lancet, and in NEJM. He chairs many national or international professional committees/groups including being the chair of the Worldwide Network for Blood and Marrow Transplant’s Nuclear Accident committee (Geneva, Switzerland), founding chair of American Society for Blood and Marrow Transplant Society’s Survivorship SIG (Chicago, Illinois), and co-chair of the Center for International Blood & Marrow Transplant Registry’s (CIBMTR) Health Services Committee (Milwaukee, Wisconsin). He is currently the chair of the Dept. of Hematology/Oncology at the SSMC, Abu Dhabi, UAE; and the chair of SEHA Oncology Council.